Browse our anti-VLDLR (VLDLR) Antibodies

Full name:
anti-Very Low Density Lipoprotein Receptor Antibodies (VLDLR)
On www.antibodies-online.com are 133 Very Low Density Lipoprotein Receptor (VLDLR) Antibodies from 19 different suppliers available. Additionally we are shipping VLDLR Kits (36) and VLDLR Proteins (8) and many more products for this protein. A total of 180 VLDLR products are currently listed.
Synonyms:
AA408956, AI451093, AW047288, CARMQ1, CHRMQ1, VLDLRCH
list all antibodies Gene Name GeneID UniProt
VLDLR 7436 P98155
VLDLR 22359 P98156
VLDLR 25696  

Show all species

Show all synonyms

Most Popular Reactivities for anti-VLDLR (VLDLR) Antibodies

Select your species and application

anti-Human VLDLR Antibodies:

anti-Mouse (Murine) VLDLR Antibodies:

anti-Rat (Rattus) VLDLR Antibodies:

All available anti-VLDLR Antibodies

Go to our pre-filtered search.

Top referenced anti-VLDLR Antibodies

  1. Human Polyclonal VLDLR Primary Antibody for ELISA - ABIN1998173 : Trommsdorff, Gotthardt, Hiesberger, Shelton, Stockinger, Nimpf, Hammer, Richardson, Herz: Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. in Cell 1999 (PubMed)
    Show all 5 references for 1998173

  2. Cow (Bovine) Monoclonal VLDLR Primary Antibody for ICC, IF - ABIN4365609 : Roberts, Barnard, Liang, Vaziri: Effect of diet on adipose tissue and skeletal muscle VLDL receptor and LPL: implications for obesity and hyperlipidemia. in Atherosclerosis 2002 (PubMed)
    Show all 5 references for 4365609

  3. Human Polyclonal VLDLR Primary Antibody for FACS, IHC (p) - ABIN651940 : Sakai, Tiebel, Ljungberg, Sullivan, Lee, Terashima, Li, Kobayashi, Lu, Chan, Oka: A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of apoE containing lipoproteins. in Brain research 2009 (PubMed)
    Show all 2 references for 651940

  4. Human Polyclonal VLDLR Primary Antibody for FACS, IF (p) - ABIN705551 : Fredriksson, Mishra, Lam, Mushaben, Cuento, Meyer, Yao, Keeran, Nugent, Qu, Yu, Yang, Raghavachari, Dagur, McCoy, Levine: The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses. in Journal of immunology (Baltimore, Md. : 1950) 2014 (PubMed)

  5. Human Monoclonal VLDLR Primary Antibody for EIA, WB - ABIN263865 : Ruiz, Kouiavskaia, Migliorini, Robinson, Saenko, Gorlatova, Li, Lawrence, Hyman, Weisgraber, Strickland: The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. in Journal of lipid research 2005 (PubMed)

More Antibodies against VLDLR Interaction Partners

Human Very Low Density Lipoprotein Receptor (VLDLR) interaction partners

  1. VLDLR expression was negatively regulated by miR (show MLXIP Antibodies)-200c Colorectal cancer (CRC (show CALR Antibodies)) cells and their expression levels were inversely correlated in CRC (show CALR Antibodies) patients.

  2. We screened for mutations in RELN (show RELN Antibodies) or VLDLR and compared the phenotype of these patients with that of previously reported patients. differences in clinical severity, involvement of the cerebellar hemispheres, together with the severity of the neocortical defect, enables RELN (show RELN Antibodies)-mutated patients to be distinguished from VLDLR-mutated patients.

  3. Data suggest that, in the binding of fibrin beta N-domains and the (1-8) peptide fragment of VLDLR (very low density lipoprotein receptor), the second and third Lys (show LYZ Antibodies)/Arg clusters in fibrin make major contributions to this interaction while the contribution of the first cluster is moderate.

  4. The presence of reelin (show RELN Antibodies) was elevated in junctional areas as in dysplastic nevi. VLDLR presented positive values in 16 cases (16/ 32) and ApoER2 (show LRP8 Antibodies) was weak positive in 7 cases.

  5. These results for the first time demonstrated that SalA protected against IS/RP-induced endothelial barrier dysfunction through suppression of VLDL receptor expression

  6. these results suggest that VLDLR functions in vivo as an HCV receptor independent of canonical CD81 (show CD81 Antibodies)-mediated HCV entry.

  7. the results obtained indicate that minimal fibrin-binding structures are located within the second and third CR domains of the VLDL receptor and the presence of the fourth CR domain is required for high-affinity binding

  8. The results of this study demonstrated the presence of reelin (show RELN Antibodies), its receptors VLDLR and ApoER2 (show LRP8 Antibodies) as well as Dab1 (show DAB1 Antibodies) in the ENS and might indicate a novel role of the reelin (show RELN Antibodies) system in regulating neuronal plasticity and pre-synaptic functions in the ENS.

  9. these results suggested that the miR (show MLXIP Antibodies)-135a-VLDLR-p38 (show CRK Antibodies) axis may contribute to gallbladder cancer cell proliferation

  10. study identified a novel homozygous VLDLR c.2248C>T mutation (p.Q750X) and distinctive MRI findings in 2 siblings with ataxia; also marked vitamin E deficiency was detected in the proband

Mouse (Murine) Very Low Density Lipoprotein Receptor (VLDLR) interaction partners

  1. C-terminal truncation of the reelin (show RELN Antibodies) protein disrupts the interaction of reelin (show RELN Antibodies) with VLDLR, resulting in abnormal development of the cerebral cortex and hippocampus.

  2. Study showed that the two major VLDLR splice variants have differential activities in regulating Wnt (show WNT2 Antibodies) signaling due to their different ectodomain shedding rates, which identified the functional difference of these splice variants.

  3. The absence of PCSK9 (show PCSK9 Antibodies) results in a sex- and tissue-specific subcellular distribution of the LDLR (show LDLR Antibodies) and VLDLR, which is determined by estradiol levels.

  4. In the retinas of Vldlr(-/-) mice with low fatty acid uptake but high circulating lipid levels, we found that Ffar1 (show FFAR1 Antibodies) suppresses expression of the glucose transporter Glut1 (show SLC2A1 Antibodies)

  5. neuronal stress differentially regulates lipoprotein receptor expression in neurons, with VLDLR upregulation as a common element as a modulator of neuronal Wnt (show WNT2 Antibodies) signaling

  6. Subretinal vascularization (SRV) in the Vldlr-/- model is associated with mistargeted neurites and that SRV is preceded by altered retinal vascular development.

  7. VLDLR requires RasGRF1 (show RASGRF1 Antibodies)/CaMKII (show CAMK2G Antibodies) to alter dendritic spine formation.

  8. This study demonstrated that VLDLR is expressed in distinct spatiotemporal patterns in developing mouse cerebral cortex.

  9. LRP5 (show LRP5 Antibodies) signaling is a prerequisite for neovascularization in VLDLR knockout mice. LRP5 (show LRP5 Antibodies) may be an effective target for inhibiting intraretinal neovascularization.

  10. these results identify a novel role for the VLDLR as a negative regulator of DC-mediated adaptive immune responses in HDM (show HDAC3 Antibodies)-induced allergic airway inflammation.

VLDLR Antigen Profile

Antigen Summary

The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene.

Alternative names and synonyms associated with VLDLR

  • very low density lipoprotein receptor (VLDLR) antibody
  • very low density lipoprotein receptor (Vldlr) antibody
  • very low density lipoprotein receptor-like (LOC100343584) antibody
  • AA408956 antibody
  • AI451093 antibody
  • AW047288 antibody
  • CARMQ1 antibody
  • CHRMQ1 antibody
  • VLDLRCH antibody

Protein level used designations for VLDLR

VLDL receptor , VLDL-R , very low-density lipoprotein receptor , VTG receptor , very low density lipoprotein (VLDL)/vitellogenin receptor , vitellogenin receptor

GENE ID SPECIES
7436 Homo sapiens
22359 Mus musculus
396154 Gallus gallus
25696 Rattus norvegicus
100725662 Cavia porcellus
733630 Sus scrofa
100008976 Oryctolagus cuniculus
476336 Canis lupus familiaris
282123 Bos taurus
101117143 Ovis aries
100343584 Oryctolagus cuniculus
Selected quality suppliers for anti-VLDLR (VLDLR) Antibodies
Did you look for something else?